(Q39234422)

10 September 2017

Rate of decline in progressive supranuclear palsy (English)

1 reference

10 September 2017

1

1 reference

10 September 2017

Maiying Kong

2

1 reference

PubMed ID

24615741

10 September 2017

language of work or name

English

0 references

publication date

24 February 2014

1 reference

10 September 2017

1 reference

10 September 2017

29

1 reference

10 September 2017

4

1 reference

10 September 2017

463-468

1 reference

The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice

10 September 2017

1 reference

The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

21 January 2018

1 reference

Prevalence and natural history of progressive supranuclear palsy

21 January 2018

1 reference

Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study

21 January 2018

1 reference

Progressive supranuclear palsy: a survey of the disease course.

21 January 2018

1 reference

Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study

21 January 2018

1 reference

Progression of gait, speech and swallowing deficits in progressive supranuclear palsy

21 January 2018

1 reference

A clinical rating scale for progressive supranuclear palsy.

21 January 2018

1 reference

Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale

21 January 2018

1 reference

21 January 2018

1 reference

The FAB: a Frontal Assessment Battery at bedside.

21 January 2018

1 reference

Clinical and posturographic correlates of falling in Parkinson's disease.

21 January 2018

1 reference

Objective biomarkers of balance and gait for Parkinson's disease using body-worn sensors

21 January 2018

1 reference

A sample size adjustment procedure for clinical trials based on conditional power.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.25843

1 reference

10 September 2017

1 reference

PubMed ID

24615741